Plasma glutathione peroxidase deficiency and platelet insensitivity to nitric oxide in children with familial stroke

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 8, 1999, Pages 2017-2023

  Kenet, Gili ^a   Freedman, Jane ^c   Shenkman, Boris ^a   Regina, Eskaraev ^e   Brok Simoni, Frida ^a   Holzman, Fanny ^a   Vavva, Fotini ^c   Brand, Nathan ^a   Michelson, Alan ^b   Trolliet, Maria ^c   Loscalzo, Joseph ^c   Inbal, Aida ^a,d  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SHEBA MEDICAL CENTER   (Israel)

^e NONE

Author keywords

Glutathione peroxidase; Nitric oxide; Platelets; Stroke

Indexed keywords

ADENOSINE DIPHOSPHATE; GLUTATHIONE PEROXIDASE; NITRIC OXIDE; PADGEM PROTEIN; S NITROSOGLUTATHIONE;

ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; ENZYME DEFECT; FAMILIAL DISEASE; FEMALE; HUMAN; INFANT; MALE; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROKE; THROMBOCYTE AGGREGATION;

EID: 0032810065     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.8.2017     Document Type: Article

References (46)

1. de Veber G, Andrew M. Canadian Pediatric Ischemic Stroke Registry. Ped Res. 1994;35:379. Abstract.
2. Schoenberg BS, Mellinger JF, Schoenberg DF. Cerebrovascular disease in infants and children: a study of incidence, clinical features, and survival. Neurology. 1978;28:763-768.
3. Broderick J, Talbot TG, Prenger E, Leach A, Brott T. Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol. 1993;8:250-255.
4. Grotta J. Cerebrovascular disease in young patients. Thromb Haemost. 1997;78:13-23.
5. Dusser A, Goutieres G, Aicardi H. Ischemic strokes in children. J Child Neurol. 1986;1:131-136.
6. Hart RG, Kanter MC. Hematologic disorders and ischemic stroke. Stroke. 1990;21:111-112.
7. Cortellaro M, Boschetti C, Cofrancessco E, Zanussi C, Catalano M, de Gaentano G, Gabrielli L, Lombardi B, Tavazzi E, Speccia G, et al. The PLAT Study hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal Results. Progetto Lombardo Artero-Trombosi (PLAT) Study Group. Arterio Thromb. 1992; 12:1063-1070.
8. Sie P, Boneu B, Bierme R, Wiesel ML, Grunebaum L, Cazenave JP. Arterial thrombosis and protein S deficiency. Thromb Haemost. 1989; 62:1040. Letter
9. Koller H, Stoll G, Sitzer M, Burk M, Schottler B, Freud HJ. Deficiency in both protein C and protein S in a family with ischemic strokes in young adults. Neurology. 1994;44:1238-1240.
10. Israels SJ, Seshia SS. Childhood stroke associated with familial protein C or S deficiency. J Pediatr. 1987;111:562-564.
11. Simioni P, Battistella PA, Drigo P, Carollo C, Girolami A. Childhood stroke associated with familial protein S deficiency. Brain Dev. 1994;16: 241-245.
12. Mayer SA, Sacco RL, Hurlet-Jensen A, Shi T, Mohr JP. Free protein S in acute ischemic stroke: a case-control study. Stroke. 1993;24:224-227.
13. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation Factor V associated with resistance to activated protein C. Nature. 1994; 369:14-15.
14. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 1993:342:1503-1506.
15. Dahlback B. New molecular insights into the genetics of thrombophilia: resistance to activated protein C caused by Arg506 to Gin mutation in Factor V as a pathogenetic risk factor for venous thrombosis. Thromb Haemost. 1995;74:139-148.
16. Martinelli I, Landi G, Merati G, Cella R, Aosetto A, Mannucci PM. Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost. 1996;75:393-394.
17. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. N Engl J Med. 1995;332:912-917.
18. Kontula K, Ylikorkala A, Miettinen H, Vuorio A, Kauppinen-Makelm R, Hamalainen L, Palomaki H, Kaste M. Arg506Gln factor V mutation (factor V Leiden) in patients with ischemic cerebrovascular disease and survivors of myocardial infarction. Thromb Haemost. 1995;73:558-560.
19. Catto A, Canter A, Ireland H, Bayston TA, Philippou H, Barrett J, Lane DA, Grant PJ. Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke. Arterioscler Thromb Vasc Biol. 1995;15:783-785.
20. Press RD, Liu XY, Breamer N, Coull BM. Ischemic stroke in the elderly: role of the common factor V mutation causing resistance to activated protein C. Stroke. 1996;27:44-48.
21. van der Born JG, Bots ML, Haverkate F, Slagboom PE, Meijer P, de Jong PT, Hofman A, Grobbee D, Kluft C. Reduced response to activated protein C is associated with increased risk for cerebrovascular disease. Am J Intern Med. 1996;125:265-269.
22. Fischer M, Fernandez JA, Ameriso SF, Xie D, Gruber A, Paganini-Hill A, Griffin JH. Activated protein C resistance in ischemic stroke not due to factor V arginine 506→glutamine mutation. Stroke. 1996;27:1163-1166.
23. De Stefano V, Chiusolo P, Paciaroni, Caorelli KI, Rossi E, Molinari M, Servictel S, Tonali PA, Leone G. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood. 1998;91:3562-2565.
24. Ganesan V, Kelsey H, Cookson J, Osborn A, Kirkham FJ. Activated protein C resistance in childhood stroke. Lancet. 1996;347:260. Letter.
25. Nowak-Gottl U, Koch HG, Aschka I, Kohlhase B, Vielhaber H, Kurlemann G, Oleszuk-Raschke K, Kehl HG, Jurgens H, Schneppenheim R. Resistance to activated protein C (APCR) in children with venous or aterial thromboembolism. Br J Haematol. 1996;92:992-998.
26. Nowak-Gottl U, Strater R, Dubbers A, Oleszuk-Raschke K, Vielhabe H. Ischaemic stroke in infancy and childhood: role of the Arg 506 to Gin mutation in the factor V gene. Blood Coagul Fibrinolysis. 1996;7: 684-688.
27. Riikonen RS, Vahtera EM, Kekomaki RM. Physiological anticoagulants and activated protein C resistance in childhood stroke. Acta Pediatr. 1996;85:242-244.
28. Andrew M, David M, deVeber G, Brooker LA. Arterial thromboembolic complications in paediatric patients. Thromb Haemost. 1997;78:715-725.
29. Malinow MR. Plasma homocysteine: a risk factor for arterial occlusive disease. J Nutr. 1996;26:1238S-1243S.
30. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GI, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate. Nat Genet. 1995;10:111-113.
31. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase and plasma homocysteine concentrations. Circulation. 1996;94:2322-2323.
32. Freyburger G, Labrouche S, Sassoust G, Rouanet F, Javaroschi S, Parrot F. Mild hyperhomocysteinemia and hemostatic factors in patients with arterial vascular diseases. Thromb Haemost. 1997:77:466-471.
33. Grandone N, D'Andrea G, D'Addeda M, Cappucci G, Grandore E, Soriente L, De Stefano V, Simone P, Toral PA, Brancaccio V, Margaglione M, Di Mirro G. Role of factor V Leiden and 5,10 MTHFR C> T677 mutations in premature ischemic stroke. Thromb Haemost. 1997;(suppl):99. Abstract.
34. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-3703.
35. Arruda VR, Annichino-Bizzacchi JM, Goncalves MS, Costa FF. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemost. 1997;78:1430-1433.
36. Corral J, Gonzalez-Conejero R, Lozano ML, Rivera R, Heras I, Vincente V. The venous thrombosis risk factor 20210A allele of the prothrombin gene is not a major risk facator for arterial thrombotic disease. Br J Haematol. 1997;99:304-307.
37. Mellion BT, Ignarro LJ, Ohlstein EH, Pontecorvo EG, Hyman AL, Kadowitz PJ. Evidence for the inhibitory role of guanosine 3′,5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood. 1981;57: 946-955.
38. Mendelsohn ME, Oneill S, George D, Loscalzo J. Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine. J Biol Chem. 1990;265:19028-19034.
39. Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 1987; 2:1057-1058.
40. Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identicial to those of nitric oxide radical. Circ Res. 1987;61:866-879.
41. Michelson AD, Benoit SE, Breckwoldt WL, Barnard MR, Rohrer MJ, Loscalzo J. Endothelium-derived relaxing factor completely inhibits activation-dependent up-regulation of platelet surface P-selectin, CD63, and the GPIIB-IIIa complex in a washed platelet system, but not in whole blood. Blood. 1992;80:510. Abstract.
42. Freedman JE, Loscalzo J, Benoit SE, Valeri CR, Barnard MR, Michelson AD. Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. J Clin Invest. 1996;97:979-987.
43. Michelson AD, Shattil SJ. The use of flow cytometry to study platelet activation. In: Watson SP, Authi K, eds: Platelet Function and Signal Transduction: A Practical Approach. Oxford, UK: Oxford: 1995: 111-127.
44. Beutler, E. Glutathione peroxidase (GSH-Px). In: Beutler E, ed: Red Cell Metabolism: A Manual of Biochemical Methods. Orlando, FL: Grune & Stratton, Inc; 1985:74-76.
45. Andrew M. Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thromb Haemost. 1995;74: 415-425.
46. Inbal A, Kenet G, Zivelin A, Yermiyahu T, Bronstein T, Sheinfeld T, Tamari H, Gitel S, Eshel G, Duchemin J, Aiach M, Seligsohn U. Purpura fulminans induced by disseminated intravascular coagulation after infection in 2 unrelated children with double heterozygosity for factor V Leiden and protein S deficiency. Thromb Haemost. 1997;77: 1086-1089.